FDLI | US-China Food and Drug Law | Overview

US-China Food and Drug Law 

Nearly 250 food and drug law professionals spent two days in Beijing exploring the US and China regulatory requirements for food, drugs, dietary supplements, medical devices and cosmetics. Leaders from FDA, SFDA and AQSIQ, as well industry and consumer experts, engaged in intense discussion.


Tweets from the Conference

AQSIQ official notes that "Food safety knows no nationality."

FDA Chief Counsel Tyler "To do our (FDA) job, we must collaborate with other regulatory agencies."

YUM! Brands leader Joaquin Pelaez "To have a successful brand in China, you must innovate constantly."

Who Attended

• Regulatory and Government Affairs, Business Development, Global Strategic Officials, Corporate Planners, and Safety and Compliance officers of multi-national food, cosmetic, dietary supplement, pharmaceutical and medical device companies doing business or planning to do business in China.
• Representatives of Chinese food, cosmetic, dietary supplement, pharmaceutical and medical device companies or those who wish to partner with these companies
• Food and Drug Attorneys
• Government Officials
• Academics
• Food and Drug Industry Consultants
• Venture Capitalists and Investment Brokers doing business in China

Continuing Legal Education (CLE) credits

Continuing Legal Education credits are available after attending this conference. FDLI applies directly to Ohio, Pennsylvania and Virginia. These states are generally recognized as approved jurisdictions by other states. Please contact your Bar Association for guidance.

 

CLE credits for the this conference are approved for the following states:

OH – 11.5 hours
PA – 14.0 hours
VA – 10.5 hours

View FDLI's Continuing Legal Education (CLE) policy.